Description
Tryptophan 2,3-Dioxygenase (TDO) Inhibitors as Anticancer ImmunomodulatorsPeriod | 15 Jul 2012 |
---|---|
Event type | Conference |
Location | Leuven, BelgiumShow on map |
Documents & Links
Related content
-
Research output
-
Synthesis, crystal and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles
Research output: Contribution to conference › Poster
-
Conception, synthèse et étude d'inhibiteurs de la tryptophane 2,3-dioxygénase (TDO), une cible prometteuse pour le traitement du cancer
Research output: Contribution to conference › Poster
-
Tryptophan 2,3-dioxygenase (TDO) inhibitors : Identification of new scaffolds using virtual screening
Research output: Contribution to conference › Poster
-
Synthesis, structural, enzymatic and cellular studies of vinyl-1H-indole analogues as potential inhibitors of tryptophan 2,3-dioxygenase (TDO), an attractive target in cancer immunotherapy.
Research output: Contribution to conference › Poster
-
SYNTHESIS, ACTIVITY, CRYSTAL AND ELECTRONIC PROPERTIES OF ISOMERS OF CHLORO-PYRIDINYLVINYL-1H-INDOLES
Research output: Contribution to conference › Poster
-
Synthesis, crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles
Research output: Contribution to journal › Article › peer-review
-
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators
Research output: Contribution to journal › Article › peer-review
-
Structural and enzymatic study of tryptophan 2.3-dioxygenase (TDO), a potential target in anticancer immunotherapy
Research output: Contribution to conference › Paper
-
Aromatic Thiosemicarazones are inhibitors of tryptophan 2,3-Dioxygenase (TDO), an emerging target for cancer treatment
Research output: Contribution to conference › Poster
-
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Research output: Contribution to journal › Article › peer-review
-
Design, synthesis and study of inhibitors of tryptophan 2,3-dioxygenase (TDO), a promising target for cancer therapy
Research output: Contribution to conference › Poster
-
coauthor on lecture: Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase (TDO): discovery of an orally active TDO inhibitor.
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
-
Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Design, Synthesis and Preclinical Evaluation of a Novel TDO Inhibitor.
Research output: Contribution to journal › Literature review › peer-review
-
THIOSEMICARBAZONES AS INHIBITORS OF TRYPTOPHAN 2,3-DIOXYGENASE (TDO), AN EMERGING TARGET FOR CANCER TREATMENT
Research output: Contribution to conference › Poster
-
Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy.
Research output: Contribution to journal › Literature review › peer-review
-
Tryptophan 2,3-Dioxygenase (TDO) Inhibitors as Anticancer Immunomodulators
Research output: Contribution to conference › Poster
-
Tryptophan 2,3-dioxygenase (TDO) inhibitors : Identification of new scaffolds using virtual screening
Research output: Contribution to conference › Poster
-
Press/Media
-
AVANCÉE SIGNIFICATIVE DANS LE TRAITEMENT DU CANCER
Press/Media: Research
-
Broadening TDO's base
Press/Media: Expert Comment
-
Cancer: Des chercheurs namurois innovent.
Press/Media: Other
-
USPJEH MLADOGA OGULINCA
Press/Media: Other
-
New target for cancer therapy identified, preclinical study shows
Press/Media: Expert Comment
-
Ogulinac Eduard Dolušić nadomak otkriću lijeka protiv raka
Press/Media: Other
-
Une avancée considérable contre la cancer
Press/Media: Other
-
Une avancée belge dans la thérapie du cancer
Press/Media: Other
-
Mladi Ogulinac u ekipi koja je na tragu lijeka protiv raka
Press/Media: Other
-
Student theses
-
Projects
-
tryptophane 2,3-dioxygénase
Project: Research